| scholarly article | Q13442814 |
| P2093 | author name string | X F Wang | |
| D A Brenner | |||
| Y O Kweon | |||
| B Schnabl | |||
| J P Frederick | |||
| R A Rippe | |||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 89-100 | |
| P577 | publication date | 2001-07-01 | |
| P1433 | published in | Hepatology | Q15724398 |
| P1476 | title | The role of Smad3 in mediating mouse hepatic stellate cell activation | |
| P478 | volume | 34 |
| Q37219104 | 3,3'-Diindolylmethane ameliorates experimental hepatic fibrosis via inhibiting miR-21 expression. |
| Q50785680 | A dual reporter gene transgenic mouse demonstrates heterogeneity in hepatic fibrogenic cell populations. |
| Q42578817 | A new fluorescence-based optical imaging method to non-invasively monitor hepatic myofibroblasts in vivo |
| Q42932434 | A nonclassical vitamin D receptor pathway suppresses renal fibrosis |
| Q37357861 | Ablation of the decorin gene enhances experimental hepatic fibrosis and impairs hepatic healing in mice. |
| Q40597763 | Amelioration of radiation-induced fibrosis: inhibition of transforming growth factor-beta signaling by halofuginone. |
| Q38343791 | Amplified expression of dominant-negative transforming growth factor-beta type II receptor inhibits collagen type I production via reduced Smad-3 activity |
| Q37122480 | Angiotensin-receptor blockers as therapy for mild-to-moderate hypertension-associated non-alcoholic steatohepatitis |
| Q41022348 | Anti-fibrotic Effects of Synthetic Oligodeoxynucleotide for TGF-β1 and Smad in an Animal Model of Liver Cirrhosis |
| Q28571978 | Antifibrotic effects of a tissue inhibitor of metalloproteinase-1 antibody on established liver fibrosis in rats |
| Q36036857 | Antifibrotic therapy in chronic liver disease |
| Q58042952 | Bone Morphogenetic Protein 7 is Elevated in Patients with Chronic Liver Disease and Exerts Fibrogenic Effects on Human Hepatic Stellate Cells |
| Q36220879 | Cell signals influencing hepatic fibrosis |
| Q50492083 | Cilostazol attenuates hepatic stellate cell activation and protects mice against carbon tetrachloride-induced liver fibrosis. |
| Q38826293 | Clonorchis sinensis lysophospholipase inhibits TGF-β1-induced expression of pro-fibrogenic genes through attenuating the activations of Smad3, JNK2, and ERK1/2 in hepatic stellate cell line LX-2. |
| Q35481673 | Commensal microbiota is hepatoprotective and prevents liver fibrosis in mice |
| Q51753112 | Connective tissue growth factor is a Smad2 regulated amplifier of transforming growth factor beta actions in hepatocytes--but without modulating bone morphogenetic protein 7 signaling. |
| Q26775055 | Current Status of Herbal Medicines in Chronic Liver Disease Therapy: The Biological Effects, Molecular Targets and Future Prospects |
| Q35956255 | Decorin-TGFβ axis in hepatic fibrosis and cirrhosis |
| Q43255957 | Development of hepatic fibrosis occurs normally in AMPK-deficient mice |
| Q36855682 | Divergent transforming growth factor-beta signaling in hepatic stellate cells after liver injury: functional effects on ECE-1 regulation |
| Q37263917 | EZH2 enhances the differentiation of fibroblasts into myofibroblasts in idiopathic pulmonary fibrosis. |
| Q39117256 | Effect of the protease inhibitor MG132 on the transforming growth factor-β/Smad signaling pathway in HSC-T6 cells |
| Q42126393 | Effect of transforming growth factor beta and bone morphogenetic proteins on rat hepatic stellate cell proliferation and trans-differentiation |
| Q35405665 | Effects of 18α-glycyrrhizin on TGF-β1/Smad signaling pathway in rats with carbon tetrachloride-induced liver fibrosis |
| Q37730812 | Efficacy of ALK5 inhibition in myelofibrosis. |
| Q36736835 | Emerging insights into Transforming growth factor beta Smad signal in hepatic fibrogenesis. |
| Q42185524 | Employment of gene expression profiling to identify transcriptional regulators of hepatic stellate cells |
| Q74601263 | Endless healing: TGF-beta, SMADs, and fibrosis |
| Q33728841 | Endoglin in liver fibrogenesis: Bridging basic science and clinical practice |
| Q24594915 | Enteric dysbiosis associated with a mouse model of alcoholic liver disease |
| Q36100069 | Ethyl acetate fraction of Amomum xanthioides improves bile duct ligation-induced liver fibrosis of rat model via modulation of pro-fibrogenic cytokines |
| Q35087770 | Expression of Smad7 in mouse eyes accelerates healing of corneal tissue after exposure to alkali |
| Q26823060 | Extracellular matrix and liver disease |
| Q47264700 | Food components with antifibrotic activity and implications in prevention of liver disease |
| Q33229156 | Ginkgo biloba extract alleviates liver fibrosis induced by CCl in rats |
| Q44487607 | Gliotoxin-mediated apoptosis of activated human hepatic stellate cells |
| Q64936019 | Graptopetalum paraguayense Inhibits Liver Fibrosis by Blocking TGF-β Signaling In Vivo and In Vitro. |
| Q50578568 | Hepatic stellate cell-specific gene silencing induced by an artificial microRNA for antifibrosis in vitro. |
| Q35124593 | Hepatic stellate cells and astrocytes: Stars of scar formation and tissue repair |
| Q53296926 | Hepatic stellate cells in inflammation-fibrosis-carcinoma axis. |
| Q35112180 | Hepatotoxicity and Mechanism of Action of Haloalkanes: Carbon Tetrachloride as a Toxicological Model |
| Q38291132 | Immortal activated human hepatic stellate cells generated by ectopic telomerase expression |
| Q34218427 | Ingredients of Huangqi decoction slow biliary fibrosis progression by inhibiting the activation of the transforming growth factor-beta signaling pathway |
| Q34414756 | Inhibition by curcumin of multiple sites of the transforming growth factor-beta1 signalling pathway ameliorates the progression of liver fibrosis induced by carbon tetrachloride in rats |
| Q36800325 | Inhibitory effect of bone morphogenetic protein-7 on hepatic fibrosis in rats |
| Q28552427 | Involvement of TGF-β1/Smad3 Signaling in Carbon Tetrachloride-Induced Acute Liver Injury in Mice |
| Q29547449 | Liver fibrosis |
| Q35068035 | Liver fibrosis -- from bench to bedside |
| Q36857873 | Liver fibrosis: possible involvement of EMT. |
| Q35744613 | Losartan reduces trinitrobenzene sulphonic acid-induced colorectal fibrosis in rats |
| Q51354315 | Low vitamin D status is associated with advanced liver fibrosis in patients with nonalcoholic fatty liver disease. |
| Q91741770 | Magnesium and liver disease |
| Q37204786 | MiR-10a improves hepatic fibrosis by regulating the TGFβl/Smads signal transduction pathway |
| Q35837968 | Microbiota Protects Mice Against Acute Alcohol-Induced Liver Injury |
| Q28303698 | Modern pathogenetic concepts of liver fibrosis suggest stellate cells and TGF-beta as major players and therapeutic targets |
| Q101133373 | Molecular and cellular mechanisms of liver fibrosis and its regression |
| Q42704568 | Molecular therapy for hepatic injury and fibrosis: where are we? |
| Q34624521 | Mutation of the 5'-untranslated region stem-loop structure inhibits α1(I) collagen expression in vivo |
| Q28216468 | Myofibroblasts and mechano-regulation of connective tissue remodelling |
| Q36524368 | NADPH oxidase signal transduces angiotensin II in hepatic stellate cells and is critical in hepatic fibrosis |
| Q80060283 | New insights from recurrent primary biliary cirrhosis in liver transplantation: the paradox of BEComing a fibroblast? |
| Q53515686 | Pivotal role of Smad3 in a mouse model of T cell-mediated hepatitis. |
| Q28477748 | Predicting in vivo anti-hepatofibrotic drug efficacy based on in vitro high-content analysis |
| Q36338112 | Prevention of TGF-β-induced early liver fibrosis by a maleic acid derivative anti-oxidant through suppression of ROS, inflammation and hepatic stellate cells activation |
| Q46588301 | Prevention of colonic fibrosis by Boswellia and Scutellaria extracts in rats with colitis induced by 2,4,5-trinitrobenzene sulphonic acid |
| Q46921370 | Protection by and anti-oxidant mechanism of berberine against rat liver fibrosis induced by multiple hepatotoxic factors |
| Q38547464 | Protective effect of fucoidan from Fucus vesiculosus on liver fibrosis via the TGF-β1/Smad pathway-mediated inhibition of extracellular matrix and autophagy. |
| Q46482143 | Protective effect of morin on dimethylnitrosamine-induced hepatic fibrosis in rats |
| Q53554147 | Receptor channel TRPC6 orchestrate the activation of human hepatic stellate cell under hypoxia condition. |
| Q26779846 | Reciprocal regulation of TGF-β and reactive oxygen species: A perverse cycle for fibrosis |
| Q37310986 | Recruitment of endogenous bone marrow mesenchymal stem cells towards injured liver |
| Q34868170 | Regulation of transforming growth factor-β1-dependent integrin β6 expression by p38 mitogen-activated protein kinase in bile duct epithelial cells |
| Q35792203 | Role of Fibroblast Growth Factor Type 1 and 2 in Carbon Tetrachloride-Induced Hepatic Injury and Fibrogenesis |
| Q33632736 | Role of NADPH oxidases in liver fibrosis |
| Q36698776 | Role of Smad3 in platelet-derived growth factor-C-induced liver fibrosis |
| Q37193215 | Rolipram attenuates bile duct ligation-induced liver injury in rats: a potential pathogenic role of PDE4 |
| Q50781080 | SMAD and p38 MAPK signaling pathways independently regulate alpha1(I) collagen gene expression in unstimulated and transforming growth factor-beta-stimulated hepatic stellate cells. |
| Q34747455 | Scleroderma and Smads: dysfunctional Smad family dynamics culminating in fibrosis |
| Q44445596 | Semaphorin 7A contributes to TGF-β-mediated liver fibrogenesis. |
| Q35649316 | Smad phosphoisoform signals in acute and chronic liver injury: similarities and differences between epithelial and mesenchymal cells |
| Q28567374 | Smad2 and Smad3 play different roles in rat hepatic stellate cell function and alpha-smooth muscle actin organization |
| Q35779047 | Smad3 as a mediator of the fibrotic response |
| Q34013157 | Smad3 knock-out mice as a useful model to study intestinal fibrogenesis |
| Q33756827 | Smad3 signaling in the regenerating liver: implications for the regulation of IL-6 expression |
| Q46845532 | Smad3 specific inhibitor, naringenin, decreases the expression of extracellular matrix induced by TGF-beta1 in cultured rat hepatic stellate cells |
| Q44507331 | Smad7 prevents activation of hepatic stellate cells and liver fibrosis in rats |
| Q37946756 | TGF-β in progression of liver disease |
| Q35102837 | Targeted disruption of TGF-beta/Smad3 signaling modulates skin fibrosis in a mouse model of scleroderma |
| Q64979975 | The Impact of a Nitric Oxide Synthase Inhibitor (L-NAME) on Ischemia⁻Reperfusion Injury of Cholestatic Livers by Pringle Maneuver and Liver Resection after Bile Duct Ligation in Rats. |
| Q37415641 | The autoregulatory feedback loop of microRNA-21/programmed cell death protein 4/activation protein-1 (MiR-21/PDCD4/AP-1) as a driving force for hepatic fibrosis development |
| Q38715538 | The rationale for targeting TGF-β in chronic liver diseases. |
| Q53592908 | The role of the miR-31/FIH1 pathway in TGF-β-induced liver fibrosis. |
| Q64378962 | Therapeutic effects of adenoviral gene transfer of bone morphogenic protein-7 on a corneal alkali injury model in mice |
| Q36371664 | Therapeutic strategies against TGF-beta signaling pathway in hepatic fibrosis |
| Q37021754 | Thyroid hormones inhibit TGF-β signaling and attenuate fibrotic responses. |
| Q36588242 | Transcriptional regulation of stellate cell activation |
| Q37023975 | Transcriptional repression of SIRT1 by protein inhibitor of activated STAT 4 (PIAS4) in hepatic stellate cells contributes to liver fibrosis |
| Q40067808 | Transforming growth factor beta mediates hepatocyte apoptosis through Smad3 generation of reactive oxygen species |
| Q80600027 | Transforming growth factor-beta and substrate stiffness regulate portal fibroblast activation in culture |
| Q42014388 | Transforming growth factor-β increases vascular smooth muscle cell proliferation through the Smad3 and extracellular signal-regulated kinase mitogen-activated protein kinases pathways |
| Q44982531 | Transient adenoviral gene transfer of Smad7 prevents injury-induced epithelial-mesenchymal transition of lens epithelium in mice |
| Q38073028 | Translating an understanding of the pathogenesis of hepatic fibrosis to novel therapies |
| Q38973928 | Ursodeoxycholyl lysophosphatidylethanolamide attenuates hepatofibrogenesis by impairment of TGF-β1/Smad2/3 signalling |
| Q36717858 | Valproic acid suppresses collagen by selective regulation of Smads in conjunctival fibrosis |
| Q35795593 | Yiguanjian decoction and its ingredients inhibit angiogenesis in carbon tetrachloride-induced cirrhosis mice |
| Q52117451 | Zebrafish Smad7 is regulated by Smad3 and BMP signals. |
Search more.